A novel glutaminase-free mammalian asparaginase with minimized immunogenicity to enable expanded use in cancer therapy
Ended Project Grant Awarded Last action
- Award ID
- R44CA228622
- Recipient
-
Enzyme By Design Inc. UEI CKUTZNUHGRN7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,849,730
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Funding
-
- $2,843,267.14 Federal
- $6,462.57 Non-federal
- Place of performance
- Illinois, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $836,804 | $0 | |
| Amendment | $836,804 | $0 | |
| Amendment | $1 | $0 | |
| Amendment | $1 | $1 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $6,462 | $0 | |
| Amendment | $6,462 | $6,462 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $1,156,734 | $0 |
Show all 14
Quick answers
Who received award R44CA228622?
R44CA228622 was awarded to Enzyme By Design Inc. by National Cancer Institute (National Institutes of Health) on July 1, 2018.
How much is award R44CA228622 worth?
$2,849,730 has been obligated on R44CA228622: $2,843,267 in federal funding and $6,463 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award